Safety of intravitreally applied epidermal growth factor receptor antibody panitumumab.

Bikbov MM, Kazakbaeva GM, Gilemzianova LI, Panda-Jonas S, Holz FG, Jonas JB.

DOI: 10.1111/aos.70235
Published: 2026-09-16
Container: Acta Ophthalmol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/aos.70235,
  title = {Safety of intravitreally applied epidermal growth factor receptor antibody panitumumab.},
  author = {Bikbov MM and  Kazakbaeva GM and  Gilemzianova LI and  Panda-Jonas S and  Holz FG and  Jonas JB.},
  year = {2026},
  journal = {Acta Ophthalmol},
  doi = {10.1111/aos.70235},
  url = {https://doi.org/10.1111/aos.70235}
}

RIS

TY  - JOUR
TI  - Safety of intravitreally applied epidermal growth factor receptor antibody panitumumab.
AU  - Bikbov MM
AU  -  Kazakbaeva GM
AU  -  Gilemzianova LI
AU  -  Panda-Jonas S
AU  -  Holz FG
AU  -  Jonas JB.
PY  - 2026
JO  - Acta Ophthalmol
DO  - 10.1111/aos.70235
UR  - https://doi.org/10.1111/aos.70235
ER  -

APA

MM, B., GM, K., LI, G., S, P., FG, H., & JB., J. (2026). Safety of intravitreally applied epidermal growth factor receptor antibody panitumumab.. Acta Ophthalmol. https://doi.org/10.1111/aos.70235

Source records

europe-pmc · retrieved 2026-09-25T09:25:47.681Z